deltatrials
Completed PHASE2 NCT00063232

Treating Nonalcoholic Steatohepatitis (NASH) With Metformin

Treatment of Nonalcoholic Steatohepatitis With Metformin

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Hepatitis
Interventions Metformin
Updated 7 times since 2017 Last updated: Jun 21, 2011 Started: Jun 30, 2003 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008

A PHASE2 clinical study on Hepatitis, this trial is completed. The trial is conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and has accumulated 7 data snapshots since 2003. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States